Skip to main content
Journal ArticleOPEN ACCESS

Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction

  • Kanelidis A
  • Premer C
  • Lopez J
  • et al.
Circulation Research (2017) 120(7) 1139-1150
DOI: 10.1161/circresaha.116.309819
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Rationale:Accumulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery. Objective:We tested the hypothesis t...

Cite

CITATION STYLE

APA

Kanelidis, A. J., Premer, C., Lopez, J., Balkan, W., & Hare, J. M. (2017). Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction. Circulation Research, 120(7), 1139–1150. https://doi.org/10.1161/circresaha.116.309819

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free